다우존스 지수

브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

등록

홈
인베스팅
주식
미국
NASDAQ
Conatus Pharmaceuticals Inc (CNAT)
Conatus Pharmaceuticals Inc (CNAT) 뉴스

CNAT

Conatus Pharmaceuticals (CNAT)

Conatus Pharmaceuticals Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:CNAT

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2020/06/06	05:03	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CNAT	Conatus Pharmaceuticals Inc
2020/06/01	21:02	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CNAT	Conatus Pharmaceuticals Inc
2020/05/30	05:11	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CNAT	Conatus Pharmaceuticals Inc
2020/05/30	05:10	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:CNAT	Conatus Pharmaceuticals Inc
2020/05/29	08:56	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CNAT	Conatus Pharmaceuticals Inc
2020/05/29	08:56	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CNAT	Conatus Pharmaceuticals Inc
2020/05/29	08:55	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CNAT	Conatus Pharmaceuticals Inc
2020/05/29	08:54	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CNAT	Conatus Pharmaceuticals Inc
2020/05/29	08:52	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CNAT	Conatus Pharmaceuticals Inc
2020/05/29	08:51	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CNAT	Conatus Pharmaceuticals Inc
2020/05/29	08:51	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CNAT	Conatus Pharmaceuticals Inc
2020/05/29	08:50	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CNAT	Conatus Pharmaceuticals Inc
2020/05/29	08:48	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:CNAT	Conatus Pharmaceuticals Inc
2020/05/29	08:47	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:CNAT	Conatus Pharmaceuticals Inc
2020/05/29	08:46	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:CNAT	Conatus Pharmaceuticals Inc
2020/05/29	08:45	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:CNAT	Conatus Pharmaceuticals Inc
2020/05/29	08:43	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:CNAT	Conatus Pharmaceuticals Inc
2020/05/29	08:42	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:CNAT	Conatus Pharmaceuticals Inc
2020/05/29	08:41	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:CNAT	Conatus Pharmaceuticals Inc
2020/05/29	08:40	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:CNAT	Conatus Pharmaceuticals Inc
2020/05/28	21:30	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CNAT	Conatus Pharmaceuticals Inc
2020/05/27	21:42	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CNAT	Conatus Pharmaceuticals Inc
2020/05/27	19:10	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CNAT	Conatus Pharmaceuticals Inc
2020/05/27	19:07	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CNAT	Conatus Pharmaceuticals Inc
2020/05/27	19:06	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CNAT	Conatus Pharmaceuticals Inc
2020/05/22	05:13	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CNAT	Conatus Pharmaceuticals Inc
2020/05/19	05:11	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:CNAT	Conatus Pharmaceuticals Inc
2020/05/18	21:00	GlobeNewswire Inc.	Leading Independent Proxy Advisory Firms Recommend Conatus Pharmaceuticals Shareholders Vote in Favor of its Merger with Hist...	NASDAQ:CNAT	Conatus Pharmaceuticals Inc
2020/05/15	05:07	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:CNAT	Conatus Pharmaceuticals Inc
2020/05/14	21:00	GlobeNewswire Inc.	Histogen Publishes Preclinical Data on its HST 004 Spinal Disc Program	NASDAQ:CNAT	Conatus Pharmaceuticals Inc

검색 관련기사 보기:NASDAQ:CNAT

1 2 3 4 5 6 7 8 9 10 다음 >>

BNP PARIBAS ISSUANCE

Citizens National Bancsh... (PK)

Therapeutics Acquisition

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관